Browse Arkansas Code titles and sections

42 U.S.C. § 284a — Advisory councils

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 284a — Advisory councils

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 284a

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 77e51dfdc607c10229cd4c7c2e5587900f514c4edf346c2e485bbdec5df06c1a. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_80f36de1476c196f818542a8
Source file: Laws/federal/codes/united-states-code/title-42/section-284a-advisory-councils--aaf0e6eeb4.md
Pages: Not recorded – Not recorded
Passage SHA-256: 32d06a82e252cc2b3a324562a4a6b304ad4a9558721bef67a030d3a18117e42c

Source location: Title 42, Chapter 6A, § 284a; chapter-6a-public-health-service.md

Stored source content

**(a) Establishment; acceptance of conditional gifts; functions** (1) Except as provided in subsection (h), the Secretary shall appoint an advisory council for each national research institute which (A) shall advise, assist, consult with, and make recommendations to the Secretary and the Director of such institute on matters related to the activities carried out by and through the institute and the policies respecting such activities, and (B) shall carry out the special functions prescribed by part C. (2) Each advisory council for a national research institute may recommend to the Secretary acceptance, in accordance with [section 238 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section238&num=0&edition=prelim), of conditional gifts for study, investigation, or research respecting the diseases, disorders, or other aspect of human health with respect to which the institute was established, for the acquisition of grounds, or for the construction, equipping, or maintenance of facilities for the institute. (3) Each advisory council for a national research institute— (A) (i) may on the basis of the materials provided under [section 289a(b)(2) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section289a/b/2&num=0&edition=prelim) respecting research conducted at the institute, make recommendations to the Director of the institute respecting such research, (ii) may review applications for grants and cooperative agreements for research or training and for which advisory council approval is required under [section 284(b)(2) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section284/b/2&num=0&edition=prelim) and recommend for approval applications for projects which show promise of making valuable contributions to human knowledge, and (iii) may review any grant, contract, or cooperative agreement proposed to be made or entered into by the institute; (B) may collect, by correspondence or by personal investigation, information as to studies which are being carried on in the United States or any other country as to the diseases, disorders, or other aspect of human health with respect to which the institute was established and with the approval of the Director of the institute make available such information through appropriate publications for the benefit of public and private health entities and health professions personnel and scientists and for the information of the general public; and (C) may appoint subcommittees and convene workshops and conferences. **(b) Membership; compensation** (1) Each advisory council shall consist of ex officio members and not more than eighteen members appointed by the Secretary. The ex officio members shall be nonvoting members. (2) The ex officio members of an advisory council shall consist of— (A) the Secretary, the Director of NIH, the Director of the national research institute for which the council is established, the Under Secretary for Health of the Department of Veterans Affairs or the Chief Dental Director of the Department of Veterans Affairs, and the Assistant Secretary of Defense for Health Affairs (or the designees of such officers), and (B) such additional officers or employees of the United States as the Secretary determines necessary for the advisory council to effectively carry out its functions. (3) The members of an advisory council who are not ex officio members shall be appointed as follows: (A) Two-thirds of the members shall be appointed by the Secretary from among the leading representatives of the health and scientific disciplines (including not less than two individuals who are leaders in the fields of public health and the behavioral or social sciences) relevant to the activities of the national research institute for which the advisory council is established. (B) One-third of the members shall be appointed by the Secretary from the general public and shall include leaders in fields of public policy, law, health policy, economics, and management. (4) Members of an advisory council who are officers or employees of the United States shall not receive any compensation for service on the advisory council. The other members of an advisory council shall receive, for each day (including traveltime) they are engaged in the performance of the functions of the advisory council, compensation at rates not to exceed the daily equivalent of the annual rate in effect for grade GS–18 of the General Schedule. **(c) Term of office; reappointment; vacancy** The term of office of an appointed member of an advisory council is four years, except that any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term and the Secretary shall make appointments to an advisory council in such a manner as to ensure that the terms of the members do not all expire in the same year. A member may serve after the expiration of the member’s term for 180 days after the date of such expiration. A member who has been appointed for a term of four years may not be reappointed to an advisory council before two years from the date of expiration of such term of office. If a vacancy occurs in the advisory council among the appointed members, the Secretary shall make an appointment to fill the vacancy within 90 days from the date the vacancy occurs. **(d) Chairman; term of office** The chairman of an advisory council shall be selected by the Secretary from among the appointed members, except that the Secretary may select the Director of the national research institute for which the advisory council is established to be the chairman of the advisory council. The term of office of the chairman shall be two years. **(e) Meetings** The advisory council shall meet at the call of the chairman or upon the request of the Director of the national research institute for which it was established, but at least three times each fiscal year. The location of the meetings of each advisory council is subject to the approval of the Director of the national research institute for which the advisory council was established. **(f) Appointment of executive secretary; training and orientation for new members** The Director of the national research institute for which an advisory council is established shall designate a member of the staff of the institute to serve as the executive secretary of the advisory council. The Director of such institute shall make available to the advisory council such staff, information, and other assistance as it may require to carry out its functions. The Director of such institute shall provide orientation and training for new members of the advisory council to provide them with such information and training as may be appropriate for their effective participation in the functions of the advisory council. **(g) Comments and recommendations for inclusion in biennial report; additional reports** Each advisory council may prepare, for inclusion in the biennial report made under section 284b 11 See References in Text note below. of this title, (1) comments respecting the activities of the advisory council in the fiscal years respecting which the report is prepared, (2) comments on the progress of the national research institute for which it was established in meeting its objectives, and (3) recommendations respecting the future directions and program and policy emphasis of the institute. Each advisory council may prepare such additional reports as it may determine appropriate. **(h) Advisory councils in existence; application of section to National Cancer Advisory Board and advisory council to National Heart, Lung, and Blood Institute** (1) Except as provided in paragraph (2), this section does not terminate the membership of any advisory council for a national research institute which was in existence on November 20, 1985. After November 20, 1985— (A) the Secretary shall make appointments to each such advisory council in such a manner as to bring about as soon as practicable the composition for such council prescribed by this section; (B) each advisory council shall organize itself in accordance with this section and exercise the functions prescribed by this section; and (C) the Director of each national research institute shall perform for such advisory council the functions prescribed by this section. (2) (A) The National Cancer Advisory Board shall be the advisory council for the National Cancer Institute. This section applies to the National Cancer Advisory Board, except that— (i) appointments to such Board shall be made by the President; (ii) the term of office of an appointed member shall be 6 years; (iii) of the members appointed to the Board— (I) not less than 5 members shall be individuals knowledgeable in environmental carcinogenesis (including carcinogenesis involving occupational and dietary factors); and (II) not less than one member shall be an individual knowledgeable in pediatric oncology; (iv) the chairman of the Board shall be selected by the President from the appointed members and shall serve as chairman for a term of two years; (v) the ex officio members of the Board shall be nonvoting members and shall be the Secretary, the Director of the Office of Science and Technology Policy, the Director of NIH, the Under Secretary for Health of the Department of Veterans Affairs, the Director of the National Institute for Occupational Safety and Health, the Director of the National Institute of Environmental Health Sciences, the Secretary of Labor, the Commissioner of the Food and Drug Administration, the Administrator of the Environmental Protection Agency, the Chairman of the Consumer Product Safety Commission, the Assistant Secretary of Defense for Health Affairs, and the Director of the Office of Science of the Department of Energy (or the designees of such officers); and (vi) the Board shall meet at least four times each fiscal year. (B) This section applies to the advisory council to the National Heart, Lung, and Blood Institute, except that the advisory council shall meet at least four times each fiscal year.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 217a — Use of Service in time of war or emergency

In time of war, or of emergency proclaimed by the President, he may utilize the Service to such extent and in such manner as shall in his judgment promote the public interest. In time of war, or of emergency involving the national defense proclaimed by the President, he may by Executive order declare the commissioned corps of the Service to be a military service. Upon such declaration, and during the period of such war or such emergency or such part thereof as the President shall prescribe, the commissioned corps (a) shall constitute a branch of the land and naval forces of the United States, (b) shall, to the extent prescribed by regulations of the President, be subject to the Uniform Code of Military Justice [[10 U.S.C. 801](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title10-section801&num=0&edition=prelim) et seq.], and (c) shall continue to operate as part of the Service except to the extent that the President may direct as Commander in Chief.

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 217a

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 238 — Health and Human Services Office on Women’s Health

**(a) Establishment of Office** There is established within the Office of the Secretary, an Office on Women’s Health (referred to in this section as the “Office”). The Office shall be headed by a Deputy Assistant Secretary for Women’s Health who may report to the Secretary. **(b) Duties** The Secretary, acting through the Office, with respect to the health concerns of women, shall— (1) establish short-range and long-range goals and objectives within the Department of Health and Human Services and, as relevant and appropriate, coordinate with other appropriate offices on activities within the Department that relate to disease prevention, health promotion, service delivery, research, and public and health care professional education, for issues of particular concern to women throughout their lifespan; 11 So in original. Probably should be “lifespans;”. (2) provide expert advice and consultation to the Secretary concerning scientific, legal, ethical, and policy issues relating to women’s health; (3) monitor the Department of Health and Human Services’ offices, agencies, and regional activities regarding women’s health and identify needs regarding the coordination of activities, including intramural and extramural multidisciplinary activities; (4) establish a Department of Health and Human Services Coordinating Committee on Women’s Health, which shall be chaired by the Deputy Assistant Secretary for Women’s Health and composed of senior level representatives from each of the agencies and offices of the Department of Health and Human Services; (5) establish a National Women’s Health Information Center to— (A) facilitate the exchange of information regarding matters relating to health information, health promotion, preventive health services, research advances, and e

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 238

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

5 U.S.C. § 5376 — Pay for certain senior-level positions

**(a)** This section applies to— (1) positions that are classified above GS–15 pursuant to section 5108; and (2) scientific or professional positions established under section 3104; but does not apply to— (A) any Senior Executive Service position under section 3132; or (B) any position in the Federal Bureau of Investigation and Drug Enforcement Administration Senior Executive Service under section 3151. **(b)** (1) Subject to such regulations as the Office of Personnel Management prescribes, the head of the agency concerned shall fix the rate of basic pay for any position within such agency to which this section applies. A rate fixed under this section shall be— (A) not less than 120 percent of the minimum rate of basic pay payable for GS–15 of the General Schedule; and (B) subject to paragraph (3), not greater than the rate of basic pay payable for level III of the Executive Schedule. The payment of a rate of basic pay under this section shall not be subject to the pay limitation of section 5306(e) or 5373. (2) Subject to paragraph (1), effective at the beginning of the first applicable pay period commencing on or after the first day of the month in which an adjustment takes effect under section 5303 in the rates of pay under the General Schedule, each rate of pay established under this section for positions within an agency shall be adjusted by such amount as the head of such agency considers appropriate. (3) In the case of an agency which has a performance appraisal system which, as designed and applied, is certified under section 5307(d) as making meaningful distinctions based on relative performance, paragraph (1)(B) shall apply as if the reference to “level III” were a reference to “level II”. (4) No employee may suffer a reduction in pay by reaso

Source: Supplied U.S. Code snapshot — release unconfirmed · 5 U.S.C. § 5376

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 284b — Repealed. Pub. L. 109–482, title I, § 104(b)(1)(C), Jan. 15, 2007, 120 Stat. 3693

### Statutory Notes Section, act July 1, 1944, ch. 373, title IV, § 407, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 831, related to biennial report and its contents. #### Effective Date of Repeal Repeal applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as an Effective Date of 2007 Amendment note under [section 281 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section281&num=0&edition=prelim).

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 284b

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 360ee — Grants and contracts for development of drugs for rare diseases and conditions

**(a) Authority of Secretary** The Secretary may make grants to and enter into contracts with public and private entities and individuals to assist in (1) defraying the costs of developing drugs for rare diseases or conditions, including qualified testing expenses, (2) defraying the costs of developing medical devices for rare diseases or conditions, (3) defraying the costs of developing medical foods for rare diseases or conditions, and (4) developing regulatory science pertaining to the chemistry, manufacturing, and controls of individualized medical products to treat individuals with rare diseases or conditions. **(b) Definitions** For purposes of subsection (a): (1) The term “qualified testing” means— (A) human clinical testing— (i) which is carried out under an exemption for a drug for a rare disease or condition under [section 355(i) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section355/i&num=0&edition=prelim) (or regulations issued under such section); and (ii) which occurs before the date on which an application with respect to such drug is submitted under [section 355(b) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section355/b&num=0&edition=prelim) or under [section 262 of title 42](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section262&num=0&edition=prelim); (B) preclinical testing involving a drug for a rare disease or condition which occurs after the date such drug is designated under [section 360bb of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360bb&num=0&edition=prelim) and before the date on which an application with respect to such drug is submitted under [section 355(b) of this title](ht

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360ee

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 281 — Organization of National Institutes of Health

**(a) Relation to Public Health Service** The National Institutes of Health is an agency of the Service. **(b) National research institutes and national centers** The following agencies of the National Institutes of Health are national research institutes or national centers: (1) The National Cancer Institute. (2) The National Heart, Lung, and Blood Institute. (3) The National Institute of Diabetes and Digestive and Kidney Diseases. (4) The National Institute of Arthritis and Musculoskeletal and Skin Diseases. (5) The National Institute on Aging. (6) The National Institute of Allergy and Infectious Diseases. (7) The Eunice Kennedy Shriver National Institute of Child Health and Human Development. (8) The National Institute of Dental and Craniofacial Research. (9) The National Eye Institute. (10) The National Institute of Neurological Disorders and Stroke. (11) The National Institute on Deafness and Other Communication Disorders. (12) The National Institute on Alcohol Abuse and Alcoholism. (13) The National Institute on Drug Abuse. (14) The National Institute of Mental Health. (15) The National Institute of General Medical Sciences. (16) The National Institute of Environmental Health Sciences. (17) The National Institute of Nursing Research. (18) The National Institute of Biomedical Imaging and Bioengineering. (19) The National Human Genome Research Institute. (20) The National Library of Medicine. (21) The National Center for Advancing Translational Sciences. (22) The John E. Fogarty International Center for Advanced Study in the Health Sciences. (23) The National Center for Complementary and Integrative Health. (24) The National Institute on Minority Health and Health Disparities. (25) Any other national center that, as an agency separate from

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 281

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 282 — Director of National Institutes of Health

**(a) Appointment** The National Institutes of Health shall be headed by the Director of NIH who shall be appointed by the President by and with the advice and consent of the Senate. The Director of NIH shall perform functions as provided under subsection (b) and as the Secretary may otherwise prescribe. **(b) Duties and authority** In carrying out the purposes of [section 241 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section241&num=0&edition=prelim), the Secretary, acting through the Director of NIH— (1) shall carry out this subchapter, including being responsible for the overall direction of the National Institutes of Health and for the establishment and implementation of general policies respecting the management and operation of programs and activities within the National Institutes of Health; (2) shall coordinate and oversee the operation of the national research institutes, national centers, and administrative entities within the National Institutes of Health; (3) shall, in consultation with the heads of the national research institutes and national centers, be responsible for program coordination across the national research institutes and national centers, including conducting priority-setting reviews, to ensure that the research portfolio of the National Institutes of Health is balanced and free of unnecessary duplication, and takes advantage of collaborative, cross-cutting research; (4) shall assemble accurate data to be used to assess research priorities, including— (A) information to better evaluate scientific opportunity, public health burdens, and progress in reducing health disparities; and (B) data on study populations of clinical research, funded by or conducted at each national research institute and

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 282

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285b–7 — National Center on Sleep Disorders Research

**(a) Establishment** Not later than 1 year after June 10, 1993, the Director of the Institute shall establish the National Center on Sleep Disorders Research (in this section referred to as the “Center”). The Center shall be headed by a director, who shall be appointed by the Director of the Institute. **(b) Purpose** The general purpose of the Center is— (1) the conduct and support of research, training, health information dissemination, and other activities with respect to sleep disorders, including biological and circadian rhythm research, basic understanding of sleep, chronobiological and other sleep related research; and (2) to coordinate the activities of the Center with similar activities of other Federal agencies, including the other agencies of the National Institutes of Health, and similar activities of other public entities and nonprofit entities. **(c) Sleep Disorders Research Advisory Board** (1) The Director of the National Institutes of Health shall establish a board to be known as the Sleep Disorders Research Advisory Board (in this section referred to as the “Advisory Board”). (2) The Advisory Board shall advise, assist, consult with, and make recommendations to the Director of the National Institutes of Health, through the Director of the Institute, and the Director of the Center concerning matters relating to the scientific activities carried out by and through the Center and the policies respecting such activities, including recommendations with respect to the plan required in subsection (c).11 So in original. Probably should be subsection “(d)”. (3) (A) The Director of the National Institutes of Health shall appoint to the Advisory Board 12 appropriately qualified representatives of the public who are not officers or employees of the Fede

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285b–7

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285c–6 — Advisory council subcommittees

There are established within the advisory council for the Institute appointed under [section 284a of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section284a&num=0&edition=prelim) a subcommittee on diabetes and endocrine and metabolic diseases, a subcommittee on digestive diseases and nutrition, and a subcommittee on kidney, urologic, and hematologic diseases. The subcommittees shall be composed of members of the advisory council who are outstanding in the diagnosis, prevention, and treatment of the diseases for which the subcommittees are established and members of the advisory council who are leaders in the fields of education and public affairs. The subcommittees are authorized to review applications made to the Director of the Institute for grants for research and training projects relating to the diagnosis, prevention, and treatment of the diseases for which the subcommittees are established and shall recommend to the advisory council those applications and contracts that the subcommittees determine will best carry out the purposes of the Institute. The subcommittees shall also review and evaluate the diabetes and endocrine and metabolic diseases, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases programs of the Institute and recommend to the advisory council such changes in the administration of such programs as the subcommittees determine are necessary.

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285c–6

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285r — Purpose of the Institute

**(a) In general** The general purpose of the National Institute of Biomedical Imaging and Bioengineering (in this section referred to as the “Institute”) is the conduct and support of research, training, the dissemination of health information, and other programs with respect to biomedical imaging, biomedical engineering, and associated technologies and modalities with biomedical applications (in this section referred to as “biomedical imaging and bioengineering”). **(b) National Biomedical Imaging and Bioengineering Program** (1) The Director of the Institute, with the advice of the Institute’s advisory council, shall establish a National Biomedical Imaging and Bioengineering Program (in this section referred to as the “Program”). (2) Activities under the Program shall include the following with respect to biomedical imaging and bioengineering: (A) Research into the development of new techniques and devices. (B) Related research in physics, engineering, mathematics, computer science, and other disciplines. (C) Technology assessments and outcomes studies to evaluate the effectiveness of biologics, materials, processes, devices, procedures, and informatics. (D) Research in screening for diseases and disorders. (E) The advancement of existing imaging and bioengineering modalities, including imaging, biomaterials, and informatics. (F) The development of target-specific agents to enhance images and to identify and delineate disease. (G) The development of advanced engineering and imaging technologies and techniques for research from the molecular and genetic to the whole organ and body levels. (H) The development of new techniques and devices for more effective interventional procedures (such as image-guided interventions). (3) (A) With respe

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285r

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.